MoneyWorks4Me

Beta Drugs - Quaterly Results

21 Jul 2026 Evaluate
A decrease in the sales to Rs. 558.26 millions was observed for the quarter ended June 2026. The sales stood at Rs. 663.25 millions during the similar quarter previous year.Good  Net Profit growth of 40.16% reported above the corresponding previous quarter figure of Rs. 42.33 millions to Rs. 59.33 millioins.OP of the company witnessed a marginal growth to 120.23 millions from 104.83 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 558.26 663.25 -15.83 558.26 663.25 -15.83 2254.30 2202.00 2.38
Other Income 18.67 29.75 -37.24 18.67 29.75 -37.24 111.43 61.92 79.96
PBIDT 120.23 104.83 14.69 120.23 104.83 14.69 396.87 376.08 5.53
Interest 16.01 27.88 -42.58 16.01 27.88 -42.58 118.07 47.56 148.25
PBDT 104.22 76.95 35.44 104.22 76.95 35.44 278.80 282.82 -1.42
Depreciation 24.85 20.38 21.93 24.85 20.38 21.93 96.69 74.42 29.92
PBT 79.37 56.57 40.30 79.37 56.57 40.30 182.11 208.40 -12.62
TAX 20.04 14.24 40.73 20.04 14.24 40.73 38.77 54.08 -28.31
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 59.33 42.33 40.16 59.33 42.33 40.16 143.34 154.32 -7.12
Equity 110.86 100.95 9.82 110.86 100.95 9.82 101.37 100.95 0.42
PBIDTM(%) 21.54 15.81 36.26 21.54 15.81 36.26 17.61 17.08 3.08
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..